メタ情報
| meta description平均長 | 163 |
|---|
| OGPありページ数 | 20 |
|---|
| Twitterカードありページ数 | 20 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 60 |
|---|
| ページあたり内部リンク平均 | 119.05 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| Event | 1 |
| Type | 0.5 |
| Location | 0.5 |
| Areas | 0.5 |
| Interest | 0.5 |
| how | 0.206958 |
| Why | 0.156821 |
| Data | 0.133588 |
| learn | 0.128736 |
| experts | 0.125 |
| our | 0.122776 |
| you | 0.121379 |
| How | 0.116163 |
| thrilled | 0.114023 |
| Visual | 0.110345 |
| booth | 0.107143 |
| Join | 0.106667 |
| Alamut | 0.106667 |
| Personal | 0.104547 |
| Platform | 0.100374 |
| Plus | 0.09931 |
| Visit | 0.098214 |
| team | 0.091954 |
| MSK | 0.088276 |
| What | 0.087123 |
| more | 0.083496 |
| Congress | 0.080357 |
| there | 0.075506 |
| statements | 0.075506 |
| development | 0.071769 |
| variant | 0.071769 |
| excited | 0.071429 |
| back | 0.071429 |
| will | 0.071061 |
| webinar | 0.069885 |
| can | 0.069882 |
| solutions | 0.069284 |
| meet | 0.062529 |
| Booth | 0.0625 |
| latest | 0.0625 |
| clinical | 0.062408 |
| challenges | 0.062408 |
| Discover | 0.062408 |
| variants | 0.062408 |
| precision | 0.060414 |
| healthcare | 0.056849 |
| explore | 0.056167 |
| across | 0.054186 |
| Liquid | 0.053571 |
| Biopsy | 0.053571 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| Event | Type | 5.641649 | 560 |
| Areas | Location | 5.279847 | 448 |
| Areas | Interest | 5.279847 | 448 |
| party | third | 5.145359 | 340 |
| Event | Location | 4.678922 | 450 |
| Diagnostic | Vitro | 4.557011 | 160 |
| EEA | United | 4.472033 | 160 |
| Kingdom | United | 4.472033 | 160 |
| Kingdom | Switzerland | 4.392788 | 160 |
| party | trademarks | 4.315718 | 260 |
| GENETICS | SOPHiA | 4.265333 | 950 |
| Alamut | Visual | 4.255201 | 110 |
| Plus | Visual | 4.218771 | 108 |
| Add | Modules | 4.199022 | 80 |
| Location | Type | 4.181179 | 338 |
| Interest | Location | 4.181179 | 338 |
| Diagnostic | Use | 4.061161 | 160 |
| clearance | governmental | 4.04363 | 84 |
| appropriate | obtain | 4.04363 | 84 |
| IVD | available | 4.00475 | 160 |
| Index | galit | 4.003595 | 80 |
| Deficiency | Recombination | 4.003595 | 80 |
| Area | Economic | 4.003595 | 80 |
| property | remain | 4.003595 | 80 |
| Unless | specifically | 4.003595 | 80 |
| endorsement | sponsorship | 4.003595 | 80 |
| Any | references | 4.003595 | 80 |
| considered | nominative | 4.003595 | 80 |
| fair | nominative | 4.003595 | 80 |
| Disorders | Inherited | 4.003595 | 80 |
| Add | Disorders | 4.003595 | 80 |
| diagnostic | procedures | 4.002037 | 84 |
| procedures | unless | 4.002037 | 84 |
| specified | unless | 4.002037 | 84 |
| otherwise | specified | 4.002037 | 84 |
| approval | received | 4.002037 | 84 |
| approval | market | 4.002037 | 84 |
| clearance | market | 4.002037 | 84 |
| governmental | regulatory | 4.002037 | 84 |
| body | regulatory | 4.002037 | 84 |
| Please | obtain | 3.98122 | 82 |
| appropriate | product | 3.962293 | 84 |
| identified | specifically | 3.960865 | 80 |
| corresponding | identify | 3.960865 | 80 |
| law | trademark | 3.960865 | 80 |
| DDM | SOPHiA | 3.958889 | 769 |
| Homologous | Recombination | 3.920123 | 80 |
| Information | Israel | 3.920123 | 80 |
| considered | shall | 3.920123 | 80 |
| trademark | under | 3.920123 | 80 |